The global Tumor Profiling market size is expected to be worth around US$ 31.08 billion by 2030, according to a new report by Vision Research Reports.
The global Tumor Profiling market size was valued at US$ 12.73 billion in 2020 and is anticipated to grow at a CAGR of 10.8% during forecast period 2021 to 2030.
Rising research in the application of omics sciences in cancer detection is anticipated to influence market growth.
Technological advances in biotechnology have allowed for deeper insights into metabolism and gene expression. These have accelerated the application of advanced techniques such as metabolomics and epigenetics in cancer screening and detection. Thus, demand for cancer tumor/profiling (CTP) techniques is anticipated to witness lucrative growth with the expansion of downstream applications.
Cancer tumor profiling is a potential procedure through which cancer can be detected and studied further to identify the stage, metabolism, and changes in morphology of the tumor. This aids in routine diagnostics as well as therapeutic decision-making. Tumor profiling has significant importance in developing therapies aimed at a specific individual, based on the severity of ailment and genomic build up of the individual.
Key techniques include omics sciences such as genomics, proteomics, epigenetics, and metabolomics. Cancer mortality rate is significantly high worldwide and cancer therapy is the most targeted field in the development of personalized medicine.
The advent of high-end technologies has enabled a possibility of detailed omics analysis of mechanisms at a molecular level, rendering a clear picture of tumor biology. These sciences have helped identify clinically feasible mutations and indicated cancers and gene and protein expression patterns.
In most of cases, cancer is known to reoccur due to continuous alterations in the genetic makeup. Genomics plays a crucial role in detection of these genetic variations in cases of recurrence. These genomic platforms have proven to be advantageous as they lead to cost savings, improve screening time, and can help in identifying a larger size of evaluated genome. These factors are likely to encourage usage of omics sciences for tumor profiling in the coming years.
Cancer tumor profiling finds application in personalized medicine, research, discovery of biomarkers, and development of screening and diagnostic techniques. Tumor profiling is most commonly used in development of precision medicine, which suits the genetic makeup of a patient to improve healing and recovery time.
There has been overwhelming demand for personalized medicine owing to advancements in technology used in treatment methods and research. This procedure is also used in oncology research and discovery of biomarkers, during the processes of drug design, discovery, and development. The segment is expected to hold the largest share in the global cancer tumor profiling market and also exhibit the fastest growth rate by 2025.
With rapid growth in gene profiling technologies and individualized targeted therapies, biomarkers are playing an important role in designing a drug regimen for cancer patients. Genome-based prognostic biomarkers are currently in use, which can be used in prognosis of several cancer types at clinical stages and also help develop drugs and therapies. However, researchers argue that the large gap between biomarker discovery stage and their clinical conversion is being hindered by challenges in conversion procedures.
Obtaining information about the genomic build of a tumor is considered as the most important step in the prognosis, diagnosis, and treatment of cancer. Next-generation sequencing (NGS) is an advanced sequencing technology that can be used for precise genomic sequencing of tumor DNA.
The interpreted data helps in the estimation of tumor purity and extent of disease advancement at a much faster rate. The main advantage of NGS is that it allows whole exome sequencing, which aids in the examination of all protein-coding regions of the human genome. It also allows for whole genome sequencing, which can be helpful in analyzing regions of protein-coding and non-coding in the human genome.
Other technologies such as microarrays are yet to be widely accepted for diagnosis and classification of cancers. Despite increased research activity in microarray technology development, only a few approaches have been refined and are being utilized for analysis of tumors and diagnostic data. Microarray technology is not limited to clinical labs but can improve the accuracy of classical diagnostic techniques by providing novel tumor-specific biomarkers.
North America is estimated to account for the largest share in terms of revenue owing to the presence of major players and rapid advances in technology. In addition, high prevalence of cancer and increased research in oncology to identify and discover novel therapy for treatment will benefit market growth. Rapid uptake of advanced technologies by firms manufacturing these diagnostics kits is another significant factor contributing to the regional market’s large share.
Illumina Inc.; Qiagen N.V.; Genomic Health; and Neogenomics Inc. lead the market with a significant share. Other key industry participants include HTG Molecular Diagnostics, Inc.; Caris Life Sciences; Helomics Corporation; Oxford Gene Technology; Nanostring Technologies; Ribomed Biotechnologies Inc.; GenomeDX; Guardant Health; and Foundation Medicine.
In Situ Hybridization
Middle East & Africa
The Tumor Profiling market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Tumor Profiling market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Tumor Profiling market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Profiling market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Tumor Profiling market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Tumor Profiling capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Tumor Profiling by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Tumor Profiling market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Tumor Profiling market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Tumor Profiling market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Tumor Profiling industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Tumor Profiling market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Tumor Profiling market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Tumor Profiling market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Tumor Profiling market. These factors have benefited the growth of the global market for Tumor Profiling. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Tumor Profiling. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Tumor Profiling are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Cancer Immunotherapy Market (By Product: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines; By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, Pancreatic Cancer) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Women’s Health App Market (By Type: Fitness & Nutrition, Menstrual Health, Pregnancy Tracking & Postpartum Care, Menopause, Disease Management) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Biopharmaceutical Third Party Logistics Market (By Supply Chain: Cold Chain, Non-cold Chain; By Service Type: Transportation, Warehousing and Storage) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Traumatic Brain Injury Assessment & Management Devices Market (By Device: Imaging Devices, Monitoring Devices; By Technique: Intracranial Pressure (ICP) Monitoring, Partial Pressure of Oxygen in Brain Tissue (pBrO2); By End-use: Hospitals, Diagnostic Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Magnetic Resonance Imaging Market (By Architecture: Closed System, Open System; By Field Strength: Low Field Strength, Mid Field Strength, High Field Strength; By Application: Brain and neurological, Spine and musculoskeletal, Vascular, Abdominal, Cardiac, Breast; By End-use: Hospitals, Imaging Centers, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...